(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Elie Azoulay 1 , Nicolas Guigue 1 , Michael Darmon 2 , Djamel Mokart 3 , Virginie Lemiale 1 , Achille Kouatchet 4 , Julien Mayaux 5 , François Vincent 6 , Martine Nyunga 1 , Fabrice Bruneel 1 , Antoine Rabbat 7 , Stéphane Bretagne 1 , Christine Lebert 8 , Anne-Pascale Meert 9 , Dominique Benoit 10 , Frédéric Pene 7 1 Medical ICU and Mycology Department, Saint-Louis Hospital, Paris, France 2 Medical-Surgical ICU, Saint-Etienne University Hospital, Saint-Étienne, France 3 Medical-Surgical ICU Paoli Calmette Cancer Institute, Marseille, France 4 Medical ICU, Angers University Hospital, Angers, France 5 Medical ICU CHU Pitié-Salpêtrière, Paris, France 6 Medical-Surgical ICU, Montfermeil Hospital, Montfermeil, France 7 Medical ICU and Pulmonary Department, Cochin Hospital, Paris, France 8 Medical-Surgical ICU, La Roche Sur Yon Hospital, La Roche Sur Yon, France 9 Medical-Surgical ICU, Jules Bordet Cancer Institute, Brussels, Belgium 10 Medical-Surgical ICU, Ghent University Hospital, Gent, Belgium Correspondence to: Elie Azoulay, e-mail: elie.azoulay@sls.aphp.fr Keywords: invasive fungal infection, intensive care units, diagnostic tests, (1–3)-beta-D-glucan assay Received: August 24, 2015 Accepted: January 19, 2016 Published: February 18, 2016 ABSTRACT Invasive fungal infections (IFIs) are life-threatening complications of hematological malignancies that must be diagnosed early to allow effective treatment. Few data are available on the performance of serum (1–3)-β-D-glucan (BG) assays for diagnosing IFI in patients with hematological malignancies admitted to the intensive care unit (ICU). In this study, 737 consecutive patients with hematological malignancies admitted to 17 ICUs routinely underwent a BG assay at ICU admission. IFIs were diagnosed using standard criteria applied by three independent specialists. Among the 737 patients, 439 (60%) required mechanical ventilation and 273 (37%) died before hospital discharge. Factors known to alter BG concentrations were identified in most patients. IFIs were documented in 78 (10.6%) patients (invasive pulmonary aspergillosis, n = 54; Pneumocystis jirovecii pneumonia, n = 13; candidemia, n = 13; and fusarium infections, n = 3). BG concentrations (pg/mL) were higher in patients with than without IFI (144 (77–510) vs. 50 (30–125), < 0.0001). With 80 pg/mL as the cutoff, sensitivity was 72%, specificity 65%, and area-under-the-curve 0.74 (0.68–0.79). Assuming a prevalence of 10%, the negative and positive predictive values were 94% and 21%. By multivariable analysis, factors independently associated with BG > 80 pg/mL were IFI, admission SOFA score, autologous bone-marrow or hematopoietic stem-cell transplantation, and microbiologically documented bacterial infection. In conclusion, in unselected critically ill hematology patients with factors known to affect serum BG, this biomarker showed only moderate diagnostic performance and rarely detected IFI. However, the negative predictive value was high. Studies are needed to assess whether a negative BG test indicates that antifungal de-escalation is safe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Marchetti, O., Lamoth, F., Mikulska, M., Viscoli, C., Verweij, P., Bretagne, S., & Groups, A. T. E. C. O. I. I. L. (. L. W. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.178 · Cited by 275
Self-citationLeone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3411-8 · Cited by 243 · cited 1×
“With antibacterial agents, de-escalation has been found feasible and safe in general ICU patients [27, 28] and in ICU patients with neutropenia [29].”
Background
Cited by
Boch, T., Reinwald, M., Spiess, B., Liebregts, T., Schellongowski, P., Meybohm, P., Rath, P.-M., Steinmann, J., Trinkmann, F., Britsch, S., et al. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.07.001 · Cited by 61
Fungal infections in immunocompromised critically ill patients
Garnacho-Montero, J., Barrero-García, I., & León-Moya, C. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.01.005 · Cited by 56
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
Giacobbe, D. R., Del Bono, V., Viscoli, C., & Mikulska, M. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1401467 · Cited by 27
Metadata
- Authors
- Azoulay, E., Guigue, N., Darmon, M., Mokart, D., Lemiale, V., Kouatchet, A., Mayaux, J., Vincent, F., Nyunga, M., Bruneel, F., Rabbat, A., Bretagne, S., Lebert, C., Meert, A.-P., Benoit, D., & Pene, F.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-02-18
- Volume
- 7
- Issue
- 16
- Pages
- 21484-21495
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2290503699
- Cited by
- 56
- References
- 6
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. https://app.cochat.ai/papers/10.18632/oncotarget.7471
- The paper
- Azoulay, E., Guigue, N., Darmon, M., Mokart, D., Lemiale, V., Kouatchet, A., Mayaux, J., Vincent, F., Nyunga, M., Bruneel, F., Rabbat, A., Bretagne, S., Lebert, C., Meert, A.-P., Benoit, D., & Pene, F. (2016). (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget. https://doi.org/10.18632/oncotarget.7471
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.